A Phase 1 Study of SY-5609, an Oral, Selective CDK7 Inhibitor, in Adult Patients With Select Advanced Solid Tumors
Clinical Trial Grant
Awarded By
SYROS PHARMACEUTICALS
Start Date
April 28, 2021
End Date
August 13, 2025
Awarded By
SYROS PHARMACEUTICALS
Start Date
April 28, 2021
End Date
August 13, 2025